0800 Immune

0800 466 863

No live vaccines for people being treated with leflunomide [letter]

Vaccination with live vaccines, such as the live herpes zoster vaccine, is not recommended for people being treated with leflunomide, nor should a live vaccine be given sooner than a period of at least 6 months has elapsed after stopping leflunomide. Leflunomide has a long half‐life. There are no clinical data on the safety of vaccination with live vaccines during treatment with leflunomide.

Publication 
Internal Medicine Journal 48(10): 1279-1280
Author 
Batty, K
Date 
4 October 2018
doi number 
doi:10.1111/imj.14056
Type of Research 
Year 
2018
Publication Date 
Thursday, October 4, 2018

Last updated: Oct 2018